|Page (1) of 1 - 07/18/12||email article||print page|
GlaxoSmithKline is to acquire its long-time partner Human Genome Sciences for about $3 billion, ending a three-month hostile pursuit of the U.S. biotech company on friendly terms after sweetening its offer.
|GSK clinches deal to buy Human Genome|
Source:GrabNetworks (c). All Rights Reserved